Minoryx Press Release
2020-11-16

Minoryx’s preclinical data for leriglitazone in Friedreich’s Ataxia published in Neurobiology of Disease Journal

Minoryx’s preclinical data for leriglitazone…
read more
Exevir Press Release
2020-11-03

ExeVir Bio Appoints Michel Kazatchkine and Stef Heylen to the Board of Directors

ExeVir Bio Appoints Michel Kazatchkine…
read more
Immunic Press Release
2020-11-02

Immunic, Inc. Announces 200 Patients Enrolled in Its Phase 2 CALVID-1 Trial of IMU-838 for the Treatment of Moderate COVID-19, Allowing for Main Phase 2 Efficacy Analysis to Proceed

Immunic, Inc. Announces 200 Patients…
read more
Minoryx Press Release
2020-11-02

European Investment Bank provides Minoryx with up to €25 million to support development of breakthrough therapies in orphan neurodegenerative diseases

European Investment Bank provides Minoryx…
read more
Immunic Press Release
2020-10-21

EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy

EIB Provides Immunic With up…
read more
Confo Therapeutics Press Release
2020-10-15

Confo Therapeutics Announces Selection of First Product Candidate and Initiation of Pre-Clinical Development

Confo Therapeutics Announces Selection of…
read more
eTheRNA Press Release
2020-10-09

eTheRNA extends senior management team with appointment of Michael Mulqueen as VP Business Development

eTheRNA extends senior management team…
read more
ONA Press Release
2020-09-28

Ona Therapeutics is named as one of Fierce Biotech’s “Fierce 15” Biotech Companies of 2020

Ona Therapeutics is named as…
read more
News article Novadip
2020-09-28

Novadip Biosciences, spin-off de l’UCLouvain et les Cliniques universitaires Saint-Luc (UCLouvain) ont réalisé une première mondiale en matière de reconstruction osseuse

Première mondiale dans le domaine…
read more
Minoryx Press Release
2020-09-23

Minoryx Therapeutics and Sperogenix Therapeutics enter into an exclusive license agreement to develop and commercialize leriglitazone in mainland China, Hong Kong and Macau

Minoryx Therapeutics and Sperogenix Therapeutics…
read more